Dr. Trevor Pugh
Dr. Trevor Pugh
Contact
Dr. Trevor Pugh
Senior Investigator & Director, Genomics

trevor.pugh@utoronto.ca

Senior Investigator & Director, Genomics

Dr. Trevor Pugh is a Senior Investigator and the Director of Genomics at OICR. He leads the OICR Genomics program, which brings together the Princess Margaret Genomics Centre, OICR’s Genome Research Platform, Translational Genomics Laboratory and Genome Sequence Informatics teams under an integrated initiative to support basic, translational and clinical research.

Dr. Pugh is a cancer genomics researcher and a board-certified molecular geneticist. His research program is focused on understanding the clinical implications of clonal shifts in cancer and non-cancerous cell populations in tumours during treatment, most recently using cell-free DNA sequencing, single cell RNA-seq analysis, and immune repertoire profiling. He and his collaborators develop software tools and data analysis systems required to enable collaborative, clinically-oriented genome research.

Experience & Education
  • Clinical Molecular Genetics Fellow (ACMG), Harvard Medical School
  • Postdoctoral Fellow, Dana-Farber Cancer Institute and the Broad Institute of Harvard and MIT
  • PhD, University of British Columbia
  • B.Sc., University of British Columbia
Current Affiliations
  • Senior Investigator & Director, Genomics, OICR
  • Canada Research Chair in Translational Genomics
  • Associate Professor, Department of Medical Biophysics, University of Toronto
  • Senior Scientist, Princess Margaret Cancer Centre
Select Publications

See Dr. Pugh’s recent publications on PubMed or on Google Scholar.

Research Areas
Biology Informatics and Data Standards
Disease Areas
All
Awards
  • Canadian Institutes of Health Research, Canada Research Chair in Translational Genomics, 2018
  • StandUp2Cancer, Philip A. Sharp Award for Innovation in Collaboration, 2018
  • Terry Fox Research Institute, New Investigator Award, 2017
Opportunities to Collaborate

For opportunities to collaborate with Dr. Pugh, please contact the PM-OICR Translational Genomics Laboratory.

Visit OICR’s Collaborative Research Resources directory for more opportunities to collaborate with OICR researchers.

Tools
  • Liquid Biopsy Sequencing: Ultra-deep targeted sequencing to detect somatic mutations in cell-free DNA
  • CapTCRSeq: A DNA hybrid capture method for assessment of T-cell receptor clonality (Similar bait set developed for the immunoglobulin / B-cell receptor loci)
Patents
  • Hybrid-capture sequencing for determining immune cell clonality, WO2017177308A1, 2017
In the News
OICR Genomics achieves CAP laboratory accreditation
OICR Genomics achieves CAP laboratory accreditation
Apr 26, 2021
OICR-affiliated researchers awarded $6.6 million in funding from CIHR
OICR-affiliated researchers awarded $6.6 million in funding from CIHR
Mar 09, 2021
Clinical trial breaks new ground on using immunotherapy for more cancer types
Clinical trial breaks new ground on using immunotherapy for more cancer types
Sep 07, 2021
Third major accreditation to help OICR Genomics power next generation of precision medicine
Third major accreditation to help OICR Genomics power next generation of precision medicine
Apr 04, 2023
OICR introduces groundbreaking test proven to find traces of cancer in blood
OICR introduces groundbreaking test proven to find traces of cancer in blood
Jul 25, 2023
The secret to stopping deadly cancer recurrences may be in your blood
The secret to stopping deadly cancer recurrences may be in your blood
Aug 11, 2023
Landmark study uses OICR Genomics test to find early signs of cancer in blood
Landmark study uses OICR Genomics test to find early signs of cancer in blood
Oct 24, 2023
Blood test detects tumours early in families with cancer
Blood test detects tumours early in families with cancer
Oct 24, 2023